MIAMI – June 25, 2019 – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for May 2019 and a record month for PharmCo revenue in Palm Beach, which increased at 98%.May 2019 sales have remained solid after April’s record-breaking month. The Company filled nearly 28,500 prescriptions between the 2 locations, an increase of 13% over the same month last year. Progressive Care recorded over $1.8 million in net revenues exclusive of PBM fees.“The Company is recording year-over-year growth despite drastic reimbursement contraction and aggressive PBM fees,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are confident that our efforts to build momentum and market penetration is producing the desired results. We expect to leverage our capabilities and the positive growth trajectory to accelerate our progress once the 2 new locations are properly integrated.Connect and stay in touch with us on social media:Progressive Care Inc.https://www.facebook.com/ProgressiveCareUS/https://twitter.com/ProgressCareUS PharmCo, LLChttps://www.facebook.com/pharmcorx/https://twitter.com/PharmCoRx About Progressive Care Inc.Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.Cautionary Statement Regarding Forward-Looking StatementsStatements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Investor Relations Contact:Armen Karapetyan, Progressive CareSenior Advisor Business DevelopmentArmen@progressivecareus.comwww.progressivecareus.comwww.pharmcopharmacy.com Public Relations Contact:Kathleen Gonzales, CMW MediaKathleen@cmwmedia.comwww.cmwmedia.com Web and Application Development Contact:Marcello Jaspan, Mass Ventures CorpMarcello@massventurescorp.comwww.massventurescorp.com
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!